Elizabeth M. Gil Ramirez

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

S. Steinberg, K. Camphausen, P. Choyke, 2021, The oncologist.